Lynparza ASCO success continues with positive ovarian cancer results

5th June 2019 Uncategorised 0

The treatment achieved a 72% objective response rate in patients with previously treated germline BRCA1/2-mutated advanced ovarian cancer.

More: Lynparza ASCO success continues with positive ovarian cancer results
Source: News